Thursday, September 1, 2016

BRIEF-Amgen says FDA approves Blincyto

* FDA approves Blincyto(Blinatumomab) for use in pediatric

patients with Philadelphia chromosome-negative relapsed or

refractory b-cell precursor acute lymphoblastic leukemia

Source text for Eikon:...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)